selected publications
- Distinct mesenchymal cell states mediate prostate cancer progression. bioRxiv : the preprint server for biology. 2023 Article GET IT
- Association Between Prosthetic Knee Effusions and Phosphodiesterase Type-5 Enzyme Inhibitor Use After Total Knee Arthroplasty: A Case Report. 2023 GET IT
- Defining cellular population dynamics at single-cell resolution during prostate cancer progression. eLife. 2022 Academic Article GET IT
-
JAK inhibition shows two faces in prostate cancer.
Nature cancer.
2022
Comment
GET IT
Times cited: 1 - A novel source of carbon monoxide for suicide attempt. 2022 GET IT
-
Extracellular Matrix in Synthetic Hydrogel-Based Prostate Cancer Organoids Regulate Therapeutic Response to EZH2 and DRD2 Inhibitors.
Advanced materials (Deerfield Beach, Fla.).
2021
Academic Article
GET IT
Times cited: 16 -
STAT5 is activated in macrophages by breast cancer cell-derived factors and regulates macrophage function in the tumor microenvironment.
Breast cancer research : BCR.
2021
Academic Article
GET IT
Times cited: 11 -
RNA Splicing Factors SRRM3 and SRRM4 Distinguish Molecular Phenotypes of Castration-Resistant Neuroendocrine Prostate Cancer.
Cancer research.
2021
Academic Article
GET IT
Times cited: 9 -
Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer.
Nature communications.
2021
Academic Article
GET IT
Times cited: 21 -
Erratum: Witschen, P.M., et al. Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer. Cancers 2020, 12, 1325.
Cancers.
2020
Article
GET IT
Times cited: 15 -
Tumor Cell Associated Hyaluronan-CD44 Signaling Promotes Pro-Tumor Inflammation in Breast Cancer.
Cancers.
2020
Academic Article
GET IT
Times cited: 13 -
N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.
The Journal of clinical investigation.
2019
Academic Article
GET IT
Times cited: 84 -
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors.
Proceedings of the National Academy of Sciences of the United States of America.
2019
Academic Article
GET IT
Times cited: 42 -
Cancer Stem Cell Phenotypes in ER+ Breast Cancer Models Are Promoted by PELP1/AIB1 Complexes.
Molecular cancer research : MCR.
2018
Academic Article
GET IT
Times cited: 17 -
Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions.
PloS one.
2017
Academic Article
GET IT
Times cited: 24 -
STAT5 deletion in macrophages alters ductal elongation and branching during mammary gland development.
Developmental biology.
2017
Academic Article
GET IT
Times cited: 17 -
Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.
Journal of hematology & oncology.
2017
Academic Article
GET IT
Times cited: 48 - ADAM17 in tumor associated leukocytes regulates inflammatory mediators and promotes mammary tumor formation. Genes & cancer. 2016 Academic Article GET IT
-
Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival.
Molecular cancer.
2015
Academic Article
GET IT
Times cited: 21 -
Activation of the FGFR-STAT3 pathway in breast cancer cells induces a hyaluronan-rich microenvironment that licenses tumor formation.
Cancer research.
2013
Academic Article
GET IT
Times cited: 51 -
The microtubule-associated protein DCAMKL1 regulates osteoblast function via repression of Runx2.
The Journal of experimental medicine.
2013
Academic Article
GET IT
Times cited: 47 -
The FGF/FGFR axis as a therapeutic target in breast cancer.
Expert review of endocrinology & metabolism.
2013
Academic Article
GET IT
Times cited: 35